Autism Treatment Market - Global Outlook and Forecast 2021-2027

March 2021 | 108 pages | ID: AF2B0CE34DA4EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Autism Treatment in Global, including the following market information:

Global Autism Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Autism Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autism Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Autism Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Autism Treatment Market Segment Percentages, By Type, 2020 (%)

• Serotonin uptake inhibitors (SSRIs)
• Insomnia drugs
• Anticonvulsants
• Antipsychotics
• Other

China Autism Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Autism Treatment Market Segment Percentages, By Application, 2020 (%)

• Hospital Pharmacies
• Retail pharmacies
• Online pharmacies
• Others

Global Autism Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Autism Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Autism Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Autism Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Pfizer
• Novartis
• Allergan
• Merck
• Eli Lilly and Company
• F. Hoffmann-La Roche
• Teva Pharmaceutical Industries
• Johnson & Johnson Services
• Bristol –Myer Squibb
• Otsuka Holdings
• Par Sterile Products
• Janssen Pharmaceuticals
• Actavis
• Curemark
• Mylan Pharmaceuticals
• Asuragen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Autism Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Autism Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AUTISM TREATMENT OVERALL MARKET SIZE

2.1 Global Autism Treatment Market Size: 2021 VS 2027
2.2 Global Autism Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Autism Treatment Players in Global Market
3.2 Top Global Autism Treatment Companies Ranked by Revenue
3.3 Global Autism Treatment Revenue by Companies
3.4 Top 3 and Top 5 Autism Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Autism Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autism Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Autism Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Autism Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Autism Treatment Market Size Markets, 2021 & 2027
  4.1.2 Serotonin uptake inhibitors (SSRIs)
  4.1.3 Insomnia drugs
  4.1.4 Anticonvulsants
  4.1.5 Antipsychotics
  4.1.6 Other
4.2 By Type - Global Autism Treatment Revenue & Forecasts
  4.2.1 By Type - Global Autism Treatment Revenue, 2016-2021
  4.2.2 By Type - Global Autism Treatment Revenue, 2022-2027
  4.2.3 By Type - Global Autism Treatment Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Autism Treatment Market Size, 2021 & 2027
  5.1.2 Hospital Pharmacies
  5.1.3 Retail pharmacies
  5.1.4 Online pharmacies
  5.1.5 Others
5.2 By Application - Global Autism Treatment Revenue & Forecasts
  5.2.1 By Application - Global Autism Treatment Revenue, 2016-2021
  5.2.2 By Application - Global Autism Treatment Revenue, 2022-2027
  5.2.3 By Application - Global Autism Treatment Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Autism Treatment Market Size, 2021 & 2027
6.2 By Region - Global Autism Treatment Revenue & Forecasts
  6.2.1 By Region - Global Autism Treatment Revenue, 2016-2021
  6.2.2 By Region - Global Autism Treatment Revenue, 2022-2027
  6.2.3 By Region - Global Autism Treatment Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Autism Treatment Revenue, 2016-2027
  6.3.2 US Autism Treatment Market Size, 2016-2027
  6.3.3 Canada Autism Treatment Market Size, 2016-2027
  6.3.4 Mexico Autism Treatment Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Autism Treatment Revenue, 2016-2027
  6.4.2 Germany Autism Treatment Market Size, 2016-2027
  6.4.3 France Autism Treatment Market Size, 2016-2027
  6.4.4 U.K. Autism Treatment Market Size, 2016-2027
  6.4.5 Italy Autism Treatment Market Size, 2016-2027
  6.4.6 Russia Autism Treatment Market Size, 2016-2027
  6.4.7 Nordic Countries Autism Treatment Market Size, 2016-2027
  6.4.8 Benelux Autism Treatment Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Autism Treatment Revenue, 2016-2027
  6.5.2 China Autism Treatment Market Size, 2016-2027
  6.5.3 Japan Autism Treatment Market Size, 2016-2027
  6.5.4 South Korea Autism Treatment Market Size, 2016-2027
  6.5.5 Southeast Asia Autism Treatment Market Size, 2016-2027
  6.5.6 India Autism Treatment Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Autism Treatment Revenue, 2016-2027
  6.6.2 Brazil Autism Treatment Market Size, 2016-2027
  6.6.3 Argentina Autism Treatment Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Autism Treatment Revenue, 2016-2027
  6.7.2 Turkey Autism Treatment Market Size, 2016-2027
  6.7.3 Israel Autism Treatment Market Size, 2016-2027
  6.7.4 Saudi Arabia Autism Treatment Market Size, 2016-2027
  6.7.5 UAE Autism Treatment Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Autism Treatment Major Product Offerings
  7.1.4 Pfizer Autism Treatment Revenue in Global (2016-2021)
  7.1.5 Pfizer Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Autism Treatment Major Product Offerings
  7.2.4 Novartis Autism Treatment Revenue in Global (2016-2021)
  7.2.5 Novartis Key News
7.3 Allergan
  7.3.1 Allergan Corporate Summary
  7.3.2 Allergan Business Overview
  7.3.3 Allergan Autism Treatment Major Product Offerings
  7.3.4 Allergan Autism Treatment Revenue in Global (2016-2021)
  7.3.5 Allergan Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Autism Treatment Major Product Offerings
  7.4.4 Merck Autism Treatment Revenue in Global (2016-2021)
  7.4.5 Merck Key News
7.5 Eli Lilly and Company
  7.5.1 Eli Lilly and Company Corporate Summary
  7.5.2 Eli Lilly and Company Business Overview
  7.5.3 Eli Lilly and Company Autism Treatment Major Product Offerings
  7.5.4 Eli Lilly and Company Autism Treatment Revenue in Global (2016-2021)
  7.5.5 Eli Lilly and Company Key News
7.6 F. Hoffmann-La Roche
  7.6.1 F. Hoffmann-La Roche Corporate Summary
  7.6.2 F. Hoffmann-La Roche Business Overview
  7.6.3 F. Hoffmann-La Roche Autism Treatment Major Product Offerings
  7.6.4 F. Hoffmann-La Roche Autism Treatment Revenue in Global (2016-2021)
  7.6.5 F. Hoffmann-La Roche Key News
7.7 Teva Pharmaceutical Industries
  7.7.1 Teva Pharmaceutical Industries Corporate Summary
  7.7.2 Teva Pharmaceutical Industries Business Overview
  7.7.3 Teva Pharmaceutical Industries Autism Treatment Major Product Offerings
  7.4.4 Teva Pharmaceutical Industries Autism Treatment Revenue in Global (2016-2021)
  7.7.5 Teva Pharmaceutical Industries Key News
7.8 Johnson & Johnson Services
  7.8.1 Johnson & Johnson Services Corporate Summary
  7.8.2 Johnson & Johnson Services Business Overview
  7.8.3 Johnson & Johnson Services Autism Treatment Major Product Offerings
  7.8.4 Johnson & Johnson Services Autism Treatment Revenue in Global (2016-2021)
  7.8.5 Johnson & Johnson Services Key News
7.9 Bristol –Myer Squibb
  7.9.1 Bristol –Myer Squibb Corporate Summary
  7.9.2 Bristol –Myer Squibb Business Overview
  7.9.3 Bristol –Myer Squibb Autism Treatment Major Product Offerings
  7.9.4 Bristol –Myer Squibb Autism Treatment Revenue in Global (2016-2021)
  7.9.5 Bristol –Myer Squibb Key News
7.10 Otsuka Holdings
  7.10.1 Otsuka Holdings Corporate Summary
  7.10.2 Otsuka Holdings Business Overview
  7.10.3 Otsuka Holdings Autism Treatment Major Product Offerings
  7.10.4 Otsuka Holdings Autism Treatment Revenue in Global (2016-2021)
  7.10.5 Otsuka Holdings Key News
7.11 Par Sterile Products
  7.11.1 Par Sterile Products Corporate Summary
  7.11.2 Par Sterile Products Business Overview
  7.11.3 Par Sterile Products Autism Treatment Major Product Offerings
  7.11.4 Par Sterile Products Autism Treatment Revenue in Global (2016-2021)
  7.11.5 Par Sterile Products Key News
7.12 Janssen Pharmaceuticals
  7.12.1 Janssen Pharmaceuticals Corporate Summary
  7.12.2 Janssen Pharmaceuticals Business Overview
  7.12.3 Janssen Pharmaceuticals Autism Treatment Major Product Offerings
  7.12.4 Janssen Pharmaceuticals Autism Treatment Revenue in Global (2016-2021)
  7.12.5 Janssen Pharmaceuticals Key News
7.13 Actavis
  7.13.1 Actavis Corporate Summary
  7.13.2 Actavis Business Overview
  7.13.3 Actavis Autism Treatment Major Product Offerings
  7.13.4 Actavis Autism Treatment Revenue in Global (2016-2021)
  7.13.5 Actavis Key News
7.14 Curemark
  7.14.1 Curemark Corporate Summary
  7.14.2 Curemark Business Overview
  7.14.3 Curemark Autism Treatment Major Product Offerings
  7.14.4 Curemark Autism Treatment Revenue in Global (2016-2021)
  7.14.5 Curemark Key News
7.15 Mylan Pharmaceuticals
  7.15.1 Mylan Pharmaceuticals Corporate Summary
  7.15.2 Mylan Pharmaceuticals Business Overview
  7.15.3 Mylan Pharmaceuticals Autism Treatment Major Product Offerings
  7.15.4 Mylan Pharmaceuticals Autism Treatment Revenue in Global (2016-2021)
  7.15.5 Mylan Pharmaceuticals Key News
7.16 Asuragen
  7.16.1 Asuragen Corporate Summary
  7.16.2 Asuragen Business Overview
  7.16.3 Asuragen Autism Treatment Major Product Offerings
  7.16.4 Asuragen Autism Treatment Revenue in Global (2016-2021)
  7.16.5 Asuragen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Autism Treatment Market Opportunities & Trends in Global Market
Table 2. Autism Treatment Market Drivers in Global Market
Table 3. Autism Treatment Market Restraints in Global Market
Table 4. Key Players of Autism Treatment in Global Market
Table 5. Top Autism Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Autism Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Autism Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Autism Treatment Product Type
Table 9. List of Global Tier 1 Autism Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autism Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Autism Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Autism Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Autism Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Autism Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Autism Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Autism Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Autism Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Autism Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Autism Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Autism Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Autism Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Autism Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Autism Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Autism Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Autism Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Autism Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Autism Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Autism Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Autism Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Autism Treatment Product Offerings
Table 32. Pfizer Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis Autism Treatment Product Offerings
Table 35. Novartis Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Allergan Corporate Summary
Table 37. Allergan Autism Treatment Product Offerings
Table 38. Allergan Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Merck Corporate Summary
Table 40. Merck Autism Treatment Product Offerings
Table 41. Merck Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Eli Lilly and Company Corporate Summary
Table 43. Eli Lilly and Company Autism Treatment Product Offerings
Table 44. Eli Lilly and Company Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 45. F. Hoffmann-La Roche Corporate Summary
Table 46. F. Hoffmann-La Roche Autism Treatment Product Offerings
Table 47. F. Hoffmann-La Roche Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Teva Pharmaceutical Industries Corporate Summary
Table 49. Teva Pharmaceutical Industries Autism Treatment Product Offerings
Table 50. Teva Pharmaceutical Industries Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Johnson & Johnson Services Corporate Summary
Table 52. Johnson & Johnson Services Autism Treatment Product Offerings
Table 53. Johnson & Johnson Services Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Bristol –Myer Squibb Corporate Summary
Table 55. Bristol –Myer Squibb Autism Treatment Product Offerings
Table 56. Bristol –Myer Squibb Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Otsuka Holdings Corporate Summary
Table 58. Otsuka Holdings Autism Treatment Product Offerings
Table 59. Otsuka Holdings Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 60. Par Sterile Products Corporate Summary
Table 61. Par Sterile Products Autism Treatment Product Offerings
Table 62. Par Sterile Products Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 63. Janssen Pharmaceuticals Corporate Summary
Table 64. Janssen Pharmaceuticals Autism Treatment Product Offerings
Table 65. Janssen Pharmaceuticals Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 66. Actavis Corporate Summary
Table 67. Actavis Autism Treatment Product Offerings
Table 68. Actavis Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 69. Curemark Corporate Summary
Table 70. Curemark Autism Treatment Product Offerings
Table 71. Curemark Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 72. Mylan Pharmaceuticals Corporate Summary
Table 73. Mylan Pharmaceuticals Autism Treatment Product Offerings
Table 74. Mylan Pharmaceuticals Autism Treatment Revenue (US$, Mn), (2016-2021)
Table 75. Asuragen Corporate Summary
Table 76. Asuragen Autism Treatment Product Offerings
Table 77. Asuragen Autism Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Autism Treatment Segment by Type
Figure 2. Autism Treatment Segment by Application
Figure 3. Global Autism Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Autism Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Autism Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autism Treatment Revenue in 2020
Figure 8. By Type - Global Autism Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Autism Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Autism Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Autism Treatment Revenue Market Share, 2016-2027
Figure 12. US Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Autism Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Autism Treatment Revenue Market Share, 2016-2027
Figure 24. China Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Autism Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Autism Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Autism Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Allergan Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Merck Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Eli Lilly and Company Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. F. Hoffmann-La Roche Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Teva Pharmaceutical Industries Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Johnson & Johnson Services Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Bristol –Myer Squibb Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Otsuka Holdings Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Par Sterile Products Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Janssen Pharmaceuticals Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Actavis Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Curemark Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Mylan Pharmaceuticals Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Asuragen Autism Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)